World Library  
Flag as Inappropriate
Email this Article

Tissue factor pathway inhibitor

Article Id: WHEBN0003150389
Reproduction Date:

Title: Tissue factor pathway inhibitor  
Author: World Heritage Encyclopedia
Language: English
Subject: Coagulation, Coagulation system, Prekallikrein, Glycoprotein Ib, GP1BA
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Tissue factor pathway inhibitor

Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
PDB rendering based on 1adz.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols  ; EPI; LACI; TFI; TFPI1
External IDs GeneCards:
RNA expression pattern
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)
RefSeq (protein)
Location (UCSC)
PubMed search

Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM.

Contents

  • Genetics 1
  • Protein structure 2
  • Interactions 3
  • See also 4
  • References 5
  • External links 6
  • Further reading 7

Genetics

The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70 kb. The gene has not been completely sequenced yet. A similar gene, termed TFPI2, has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.

Protein structure

TFPI has a relative molecular mass of 34,000 to 40,000 depending on the degree of proteolysis of the C-terminal region.

TFPI consists of a highly negatively charged amino-terminus, three tandemly linked Kunitz domains, and a highly positively charged carboxy-terminus. With its Kunitz domains, TFPI exhibits significant homology with human inter-alpha-trypsin inhibitor and bovine basic pancreatic trypsin inhibitor.

Interactions

Tissue factor pathway inhibitor has been shown to interact with Factor X.[1]

See also

References

  1. ^ Broze, G J; Warren L A; Novotny W F; Higuchi D A; Girard J J; Miletich J P (Feb 1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action". Blood (UNITED STATES) 71 (2): 335–43.  

External links

Further reading

  • Broze GJ, Girard TJ, Novotny WF (1991). "Regulation of coagulation by a multivalent Kunitz-type inhibitor.". Biochemistry 29 (33): 7539–46.  
  • McVey JH (2000). "Tissue factor pathway.". Baillieres Best Pract. Res. Clin. Haematol. 12 (3): 361–72.  
  • Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP (2002). "Structure and biology of tissue factor pathway inhibitor.". Thromb. Haemost. 86 (4): 959–72.  
  • Witt I (2002). "[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology]". Hamostaseologie 22 (2): 30–5.  
  • Lwaleed BA, Bass PS (2006). "Tissue factor pathway inhibitor: structure, biology and involvement in disease.". J. Pathol. 208 (3): 327–39.  
  • Van der Logt CP, Kluck PM, Wiegant J, et al. (1992). "Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization.". Hum. Genet. 89 (5): 577–8.  
  • Higuchi DA, Wun TC, Likert KM, Broze GJ (1992). "The effect of leukocyte elastase on tissue factor pathway inhibitor.". Blood 79 (7): 1712–9.  
  • van der Logt CP, Reitsma PH, Bertina RM (1991). "Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation.". Biochemistry 30 (6): 1571–7.  
  • Girard TJ, Eddy R, Wesselschmidt RL, et al. (1991). "Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2.". J. Biol. Chem. 266 (8): 5036–41.  
  • Wun TC, Kretzmer KK, Girard TJ, et al. (1988). "Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.". J. Biol. Chem. 263 (13): 6001–4.  
  • Novotny WF, Girard TJ, Miletich JP, Broze GJ (1989). "Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.". J. Biol. Chem. 264 (31): 18832–7.  
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.". Thromb. Res. 55 (1): 37–50.  
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.". Nature 338 (6215): 518–20.  
  • Broze GJ, Miletich JP (1987). "Characterization of the inhibition of tissue factor in serum.". Blood 69 (1): 150–5.  
  • Broze GJ, Warren LA, Novotny WF, et al. (1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.". Blood 71 (2): 335–43.  
  • Rao LV, Rapaport SI (1987). "Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.". Blood 69 (2): 645–51.  
  • Stubbs MT, Huber R, Bode W (1996). "Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.". FEBS Lett. 375 (1-2): 103–7.  
  • Warshawsky I, Bu G, Mast A, et al. (1995). "The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.". J. Clin. Invest. 95 (4): 1773–81.  
  • Broze GJ, Lange GW, Duffin KL, MacPhail L (1995). "Heterogeneity of plasma tissue factor pathway inhibitor.". Blood Coagul. Fibrinolysis 5 (4): 551–9.  


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.